University of California San Francisco
Give to UCSF
The UCSF Graduate Division has published the first comprehensive study of career outcomes for UCSF’s postdoctoral scholars and possibly the largest single-institution study on the subject conducted to date.
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
UC San Francisco researchers have shed light on how the immune system of a fetus can run amok, triggering inflammation in the developing intestines that protrude outside of the body through a hole beside the belly button.
Direct-to-consumer commercial telemedicine sites remotely treating patients for skin disease engaged in practices that put patients’ health and safety at risk.
UCSF has received a four-year, $2.4 million National Institutes of Health grant for an international study on the potential of femoral fractures from osteoporosis drugs.
Results from the largest single study of the genetic and environmental causes of asthma in African-American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population, raising concerns for clinicians and scientists working to stem the asthma epidemic among African-Americans.
Approximately 50 percent of current and ex-smokers with normal lung function have chronic breathing symptoms and flare-ups that are similar to patients with a disease that is the nation’s third most common killer, according to a multisite study led by UCSF.
A new national analysis by UCSF of health care expenditures associated with smoking estimates that a 10 percent decline in smoking in the U.S. would be followed a year later by an estimated $63 billion reduction in total national health care costs.
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
A 27-year-old drug for anemia may protect newborns at high risk for brain damage, according to the results of a multisite trial led by researchers at UCSF.
Proper communication between the left and right sides of the brain is critical for the development of advanced language skills, according to new research by UC San Francisco scientists.
Refugees who fled to Europe a generation ago are significantly more likely to have developed type 2 diabetes if they initially settled in poor neighborhoods, according to a study of 60,000 refugees who came to Sweden between 1987 and 1991.
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
New research by UCSF scientists could accelerate – by 10 to 100-fold – the pace of many efforts to profile gene activity, ranging from basic research into how to build new tissues from stem cells to clinical efforts to detect cancer or auto-immune diseases by profiling single cells in a tiny drop of blood.
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
Stem cell biologists at UCSF have demonstrated that IL-1 itself directly transforms the blood system by driving blood stem cells in the bone marrow to switch away from their restorative, rejuvenating role in blood renewal and towards emergency production of immune cells.
Global malaria eradication is possible within a generation, but only with renewed focus, new tools and sufficient financial support, according to a paper published in The Lancet by the Global Health Group’s Malaria Elimination Initiative at UCSF.
Frontotemporal dementia, the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.
In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
To keep a person's heart healthy, clinicians recommend avoiding risk factors such as smoking or excessive weight gain. But one risk factor, which cannot be changed, is being South Asian.
Nurse interactions with pharmaceutical and device companies are commonplace and beneficial, but they also can lead to conflicts of interest regarding drug treatment and purchasing decisions, according to researchers at UCSF.
This week, the Diabetes Center at UCSF announced that it has embarked on a precision medicine initiative with Yes Health, an all-mobile program to prevent type 2 diabetes.
Learn more about some of the UCSF researchers who received the top funding from the National Institutes of Health in 2015.
For the third year in a row, UCSF's four schools — of Dentistry, Medicine, Nursing and Pharmacy — topped the nation in federal biomedical research funding in their fields, according to 2015 figures from the National Institutes of Health.
Strengthening the link between Zika virus and microcephaly, scientists at UCSF have discovered that a protein the virus uses to infect skin cells and cause a rash is present also in stem cells of the developing human brain and retina.
An international team of scientists have for the first time identified genes and gene regulatory elements that are essential in wing development in the Natal long-fingered bat (Miniopterus natalensis), a species widely distributed in eastern and southern Africa.
